Edition:
United States

Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

27.58USD
20 Jan 2017
Change (% chg)

$0.35 (+1.29%)
Prev Close
$27.23
Open
$27.26
Day's High
$27.70
Day's Low
$26.93
Volume
109,434
Avg. Vol
170,029
52-wk High
$33.96
52-wk Low
$22.00

Select another date:

Tue, Nov 1 2016

BRIEF-Genomic Health Q3 loss per share $0.08

* Genomic Health reports third consecutive quarter of double-digit revenue growth in announcement of third quarter 2016 financial results

BRIEF-Genomic Health reports positive topline clinical validation study results

* Genomic Health announces positive topline clinical validation study results demonstrating Oncotype DX prostate cancer test predicts risk of metastasis and mortality Source text for Eikon: Further company coverage:

BRIEF-Genomic Health files for mixed shelf of up to $350 mln - SEC filing

* Files for mixed shelf of up to $350 million - SEC filing Source: (http://bit.ly/2b0l97v ) Further company coverage:

BRIEF-Genomic Health posts Q2 loss per share $0.18

* Is raising low end of both revenue and test guidance for full-year ending December 31, 2016

Select another date: